Abstract
Malignant pleural mesothelioma carries a high symptom burden. This chapter discusses palliative care options for the alleviation of suffering due to breathlessness, pain and other symptoms that are related to this devastating disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bibby A, Tsim S, Kanellakis N, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. European Respiratory Review. Dec 2016;25(142):472–86.
Clayson H, The experience of mesothelioma in Northern England. PhD thesis. University of Sheffield, Sheffield, UK. 2007.
Cairncross G, et al. ‘You can’t do anything like you used to’: an Australian study of the implications of Asbestos-related disease for both caregivers and society. International Journal of Health, Safety and Environments (IJHSE). 2018;4(3):236–47.
Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479–95.
BTS British Thoracic Society Standards of Care Committee. BTS statement on malignant mesothelioma in the UK, 2007 Thorax 2007;62:Suppl 2, ii1–ii19.
Saunders J, Ashton M, Hall C, et al. Pain management in patients with malignant mesothelioma: challenges and solutions Lung Cancer: Targets and Therapy 2019;10:37–46.
World Health Organization. WHO definition of palliative care 2002. http://www.who.int/cancer/palliative/definition/en/. Accessed 1 Sep. 2019.
Mercadante Macleod N, Kelly C, Stobo J, et al. Pain in malignant pleural mesothelioma: a prospective characterization study. Pain Med. 2016;17(11):2119–26.
Nowak A, Stockler MR, Byrne MJ. Assessing quality of life during chemotherapy for mesothelioma: feasibility, validity, and results of using the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol. 2004;22:3172–80.
Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307:2383–9.
Thomason R, Schlegel W, et al. Primary malignant mesothelioma of the pericardium. Texas Heart Institute J. 1994;21:170–4.
Ahmedzai S, Clayson H. Supportive and palliative care in mesothelioma. In: O’Byrne K, Rusch V, editors. Malignant pleural mesothelioma. New York: Oxford University Press Inc; 2006.
Hutchinson A, Barclay-Klingle N, Galvin K, Johnson M. Living with breathlessness: a systematic literature review and qualitative synthesis. European Respiratory Journal 2018;51(2):1701477. https://erj.ersjournals.com/lens/erj/51/2/1701477. Accessed 22 Sep. 2019.
Bredin M, Corner J, Krishnasamy M, et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999;318(7188):901–4.
Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;2:CD005623.
Bausewein C, Booth S, et al. Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliative Care. 2010;2:22.
Campbell ML, Yarandi H, Dove-Medows E. Oxygen is nonbeneficial for most patients who are near death. J Pain Symptom Management. 2013;45(3):517–23.
Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3:CD011008.
Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manag. 2011;42(3):388–99.
Allard P, Lamontagne C, et al. How effective are supplementary doses of opioids for dyspnoea in terminally ill cancer patients? A randomised continuous sequential clinical trial. J Pain Symptom Management. 1999;17:256–65.
Scottish Palliative Care Guidelines 2019. Breathlessness. NHS Scotland 2019. https://www.palliativecareguidelines.scot.nhs.uk. Accessed 1 Sep. 2019.
Saunders CM. The management of terminal malignant disease. 1st ed. London: Edward Arnold; 1978.
Mercadante S, Degiovanni D, Casuccio A. Symptom burden in mesothelioma patients admitted to home palliative care. Curr Med Res Opin. 2016;32(12):1985–1988. https://www.ncbi.nlm.nih.gov/pubmed/27532369. Accessed 21 Sep. 2019.
World Health Organisation. Cancer pain relief and palliative care: report of a WHO expert committee. Tech. Rep. Ser. 804. Geneva: WHO, 1990.
Leung L. From ladder to platform: a new concept for pain management. J Prim Health Care. 2012;4(3):254–8.
Strong opioids for pain management for adults in palliative care. Best Practice. https://bpac.org.nz/BPJ/2012/December/docs/bpj_49_opioids_pages_8-17.pdf. Accessed 23 Sep. 2019.
Scottish palliative care guidelines. Choosing and changing opioids. NHS Scotland. https://www.palliativecareguidelines.scot.nhs.uk/guidelines/pain/choosing-and-changing-opioids.aspx. Accessed 23 Sep. 2019.
Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med. 2011;25:553–9.
Akmansu M, Erpolat OP, Goksel F, Tunc E, Ozturk C. Radiotherapy applications of patients with malignant mesothelioma: a single center experience. Rep Pract Oncol Radiother. 2012;18(2):82–6.
Feizerfan A, Antrobus JHL. Role of percutaneous cervical cordotomy in cancer pain management. Cont Educ Anaesth Crit Care Pain. 2014;14(1):23–6.
MacLeod N, Chalmers A, O’Rourke N. Is radiotherapy useful for treating pain in mesothelioma?: a phase II trial. J Thoracic Oncol. 2015;10(6):944–50.
Ashton M, O’Rourke N, Macleod N, et al. SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma. Clin Transl Radiat Oncol. 2018;8:45–9.
Dev R, Wong A, et al. The evolving approach to management of cancer cachexia. Oncology Journal. January 15, 2017. https://www.cancernetwork.com/oncology-journal/evolving-approach-management-cancer-cachexia. Accessed 12 Sep. 2019.
Scottish palliative care guidelines. Nausea and vomiting. NHS Scotland. https://www.palliativecareguidelines.scot.nhs.uk/guidelines/pain/choosing-and-changing-opioids.aspx. Accessed 23 Sep. 2019.
Scottish palliative care guidelines. Symptom control. NHS Scotland. https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control. Accessed 1 Sep. 2019.
Dooley J, Wilson JP et al. Stress and depression of facing death: investigation of psychological symptoms in patients with mesothelioma. Australian Journal of Psychology 2011;62:3. https://aps.onlinelibrary.wiley.com/doi/abs/10.1080/00049530903510757. Accessed 13 Sep. 2019.
Hughes N, Arber A. The lived experience of patients with pleural mesothelioma. Int J Palliat Nurs. 2008;14:66–71.
Arber A, Spencer L. ‘It’s all bad news’: the first 3 months following a diagnosis of malignant pleural mesothelioma. Psycho-Oncology. 2013;22:528–1533.
Buultjens J, Cairncross G, Tucker J, Sen S. ‘You can’t do anything like you used to’: an Australian study of the implications of asbestos-related disease for both caregivers and society. ASJ: International Journal of Health, Safety and Environments (IJHSE). 2018;4(03):236–47.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Clayson, H. (2021). Palliative Treatment in Mesothelioma: How to Manage Clinical Symptoms in Mesothelioma. In: Nakano, T., Kijima, T. (eds) Malignant Pleural Mesothelioma. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-15-9158-7_19
Download citation
DOI: https://doi.org/10.1007/978-981-15-9158-7_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-9157-0
Online ISBN: 978-981-15-9158-7
eBook Packages: MedicineMedicine (R0)